metformin has been researched along with fructose 2,6-diphosphate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agius, L; Al-Oanzi, ZH; Alshawi, A; Arden, C; Fountana, S; Moonira, T; Patman, G; Petrie, JL; Reeves, HL; Tudhope, SJ | 1 |
Cai, Z; Liu, X; Lv, N; Yan, H; Zhang, E; Zhao, Y | 1 |
2 other study(ies) available for metformin and fructose 2,6-diphosphate
Article | Year |
---|---|
Opposite effects of a glucokinase activator and metformin on glucose-regulated gene expression in hepatocytes.
Topics: Active Transport, Cell Nucleus; Animals; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Cells, Cultured; Diet, Western; Enzyme Activators; Fructose; Fructosediphosphates; Gene Expression Regulation, Enzymologic; Glucokinase; Glucose-6-Phosphatase; Glucose-6-Phosphate; Hepatocytes; Hypoglycemic Agents; Male; Metformin; Mice, Inbred C3H; Overweight; Promoter Regions, Genetic; Pyruvate Kinase; Rats, Wistar; Thiazoles | 2017 |
The synergistic effect of PFK15 with metformin exerts anti-myeloma activity via PFKFB3.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Enzyme Inhibitors; Fructosediphosphates; Glucose; Humans; Hypoglycemic Agents; Metformin; Multiple Myeloma; Phosphofructokinase-2; Pyridines; Quinolines; RNA, Messenger; Signal Transduction | 2019 |